Anjali Pawar, M.D.

Health Sciences Clinical Professor, Department of Pediatrics

To see if Anjali Pawar is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).



Pediatric Hematology/Oncology



Locations and Contact

2279 45th Street
Sacramento, CA 95817

Get Directions

Additional Numbers

Clinic Fax


Clinic Referral Phone


Physician Referrals

800-4-UCDAVIS (800-482-3284)

Philosophy of Care

My philosophy of care is that the medical condition does not define my patient or the family. It just happens to be a facet presented to us out of 100s of different facets that describes the whole individual. It is not just the patient but the whole family including the siblings that are affected by the diagnosis, and I take care to be attentive to the whole family’s well being. In this I am assisted by my whole team, without whom I would not be able to care so excellently for my patients. Besides, medicine, I believe in importance of other integrative therapies like mindfulness and encourage my patients and their families to discuss their resources with our team.

Clinical Interests

Dr. Pawar is a board certified Pediatric Hematologist Oncologist, and takes great pride in providing excellent care to the affected population. Her areas of interest are leukemias, lymphomas and benign hematological conditions affecting red cells, white cells and platelet disorders, and has achieved special expertise in bleeding and clotting disorders. Being able to offer state of art and cutting edge therapy by participating in numerous clinical trials at this institute has been the highlight of her practice. Besides medical care, quality of life for the patients and their families has always been very important for her. To this end she works across other departments in the institution as well as other divisions within the department of pediatrics to offer the best care for her patients.

Research/Academic Interests

Dr. Pawar's research focuses on improving quality of life in pediatric hematology oncology patients by bringing in international trials for medical products that can make their journey better. She is also interested in machine learning and artificial intelligence as it applies to her area of expertise.


Pediatric Hematology/Oncology

Center/Program Affiliation

UC Davis Children's Hospital
UC Davis Comprehensive Cancer Center

Medical School

M.B.B.S., Karnataka Institute of Medical Sciences, Hubli, Karnataka, India 1980

Other School

D.G.O., Dr. Vaishampayan Memorial Government Medical College, Solapur, Maharashtra, India 1982


Pediatrics, Michigan State University and Sparrow Hospital, East Lansing MI 2002-2005


Pediatric Hematology/Oncology, Mott Children’s Hospital, University of Michigan, Ann Arbor MI 2005-2008

Sacramento Magazine’s Top Doctors for Pediatric Hematology Oncology, 2018, 2019

DIVERSITY Study Investigators: Male C, Mondelaers V, van den Akker M, Labarque V, Van Geet C, Petrilli A, Saraiva J, Annichino Bizzachi JM, Brandão LR, Amid A, Halton J, David M, Silva M, Hadacova I, Zapletal O, Kuhn T, Novak Z, Votava T, Hoffmann M, Ovaert C, Kramm C, Reschke M, Groll A, Kiss C, Revel-Vilk S, Luciani M, Chistolini A, Saracco P, Siragusa S, Zilinskaite V, Paredes Aguilera RA, Aarli A, Glosli H, Nurmeev I, Svirin P, Galustyan A, Zvereva T, Gorbatikov K, Trunina I, Malievskiy V, Frisk T, Albiseti M, Lin MC, Sosothikul D, Kavakli RK, Celkan T, Kupesiz A, Sasmaz I, Caliskan U, Aytac S, Ozdemir , Dihitiar V, Dmytriiev D, Kizyma Z, Corrales-Medina F, Pawar A, Felgenhauer J, Cockrell E, Ikeda A, Harkins Druzgal C, Alatkar Sharathkumar A, Dixon N, Croteau SE. Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children. Blood. 2020;135(7):491-504.

Jaffray J, Staber JM, Malvar J, Sidonio R, Haley KM, Stillings A, Weyand A, Hege K, Shilpa Jain S, Gupta S, Agnew C, Wheeler A, Pawar A, Sharma M, Chitlur M, O'Brien SH, Kouides P. Laboratory misdiagnosis of von Willebrand disease in post‐menarchal females: A multi‐center study. Am J Hematol. 2020 May 17. doi:10.1002/ajh.25869. Online ahead of print.

Pawar A, Kulkarni R. Chapter on Quality of Life in adolescent females with blood disorders; in the text book Hematology in the Adolescent Female, Publisher Springer International Publishing; Hardcover ISBN 978-3-030-48445-3. 2020.

Pawar A, Velcheti V, Lal LS, Le L, Andrade K, Desai I, Patwardhan P. Retrospective EHR Study on Effectiveness of Eltrombopag in Cancer Treatment-Related Thrombocytopenia. Blood. 2019 Nov;134(1):1100-1100. doi:10.1182/blood-2019-124781

Tullius BP, Shankar SP, Cole S, Triano V, Aradhya S, Huang EC, Sanchez T, Pawar A. Novel heterozygous mutation in the PTEN gene associated with ovarian germ cell tumor complicated by growing teratoma syndrome and overgrowth in a two‐year‐old female. Pediatric Blood & Cancer. 2019 Aug;66(8):e27788. doi:10.1002/pbc.27788. Epub 2019 Apr 30.

McCullough A, Ruehrdanz A, Jenkins MA, Gilmer MJ, Olson J, Pawar A, Holley L, Sierra-Rivera S, Linder DE, Pichette D, Grossman NJ, Hellman C, Guérin NA, O'Haire ME. Measuring the Effects of an Animal-Assisted Intervention for Pediatric Oncology Patients and Their Parents: A Multisite Randomized Controlled Trial. J Pediatr Oncol Nurs. 2018;38(3):159-177.

McCullough A, Jenkins MA, Ruehrdanz A, Gilmer MJ, Olson J, Pawar A, Holley L, Sierra-Rivera S, Linder DE, Pinchette D, Grossman NJ, Hellman C, Guerin NA, O'Haire ME. Physiological and behavioral effects of animal-assisted interventions on therapy dogs in pediatric oncology settings. Applied Animal Behaviour Science. 2017 December;200:86-95. 2018. doi:10.1016j.applanim.2017.11.014.

Song JY, Pawar A, Collins C. A novel variant mutation for congenital dyserythropoietic anemia, type II. Blood Cells Mol Dis. 2014 Dec;53(4):272-3. doi:10.1016/j.bcmd.2014.04.003. Epub 2014 May 5.

Pawar A, Botolin D, Mangelsdorf DJ, Jump DB. The role of liver X receptor-alpha in the fatty acid regulation of hepatic gene expression. J Biol Chem. 2003 Oct 17;278(42):40736-43.

Pawar A, Jump DB. Unsaturated fatty acid regulation of peroxisome proliferator-activated receptor alpha activity in rat primary hepatocytes. J Biol Chem. 2003 Sep 19;278(38):35931-9.